Recent deaths linked to chemotherapy drugs have prompted doctors to increase genetic testing before treatment. These tests identify gene variants that can cause severe toxicity in some patients. Thousands of people may be affected by these genetic differences, leading to harsh and sometimes fatal reactions to standard chemotherapy doses.
Genetic testing allows doctors to personalize cancer treatment. By analyzing a patient's genes, they can determine if a standard chemo dose is likely to cause harm. If a risk is identified, doctors can lower the dose or choose a different treatment option altogether. This approach aims to reduce the chances of severe side effects and improve the overall effectiveness of cancer therapy.
The growing use of genetic testing represents a significant step forward in cancer care. It allows for a more targeted and individualized approach, minimizing the risks associated with traditional chemotherapy regimens. As research continues, more genetic markers are likely to be identified, further enhancing the ability to predict and prevent chemo toxicity.
Genetic Testing Helps Prevent Chemotherapy Toxicity
Doctors are using genetic tests to identify patients at risk of severe side effects from chemotherapy drugs. This comes as concerns grow about deaths linked to adverse reactions to chemo. The tests help doctors adjust dosages or choose alternative treatments. By understanding a patient's genetic makeup, doctors can personalize cancer care and improve patient safety.
Source: Read the original article at NBC